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Early life opportunities for prevention of diabetes
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Abstract
Background: The global burden of diabetes and other non-communicable diseases is rising dramatically
worldwide and is causing a double poor health burden in low- and middle-income countries. Early life influences
play an important part in this scenario because maternal lifestyle and conditions such as gestational diabetes and
obesity affect the risk of diabetes in the next generation. This indicates important periods during the lifecourse
when interventions could have powerful affects in reducing incidence of non-communicable diseases. However,
interventions to promote diet and lifestyle in prospective parents before conception have not received sufficient
attention, especially in low- and middle-income countries undergoing socio-economic transition.
Discussion: Interventions to produce weight loss in adults or to reduce weight gain in pregnancy have had limited
success and might be too late to produce the largest effects on the health of the child and his/her later risk of
non-communicable diseases. A very important factor in the prevention of the developmental component of
diabetes risk is the physiological state in which the parents enter pregnancy. We argue that the most promising
strategy to improve prospective parents’ body composition and lifestyle is the promotion of health literacy in
adolescents. Multiple but integrated forms of community-based interventions that focus on nutrition, physical
activity, family planning, breastfeeding and infant feeding practices are needed. They need to address the wider
social economic context in which adolescents live and to be linked with existing public health programmes in
sexual and reproductive health and maternal and child health initiatives.
Summary: Interventions aimed at ensuring a healthy body composition, diet and lifestyle before pregnancy offer a
most effective solution in many settings, especially in low- and middle-income countries undergoing
socio-economic transition. Preparing a mother, her partner and her future child for “the 1000 days”, whether from
planned or unplanned conception would break the cycle of risk and demonstrate benefit in the shortest possible
time. Such interventions will be particularly important in adolescents and young women in disadvantaged groups
and can improve the physiological status of the fetus as well as reduce the prevalence of pregnancy conditions
such as gestational diabetes mellitus which both predispose to non-communicables diseases in both the mother
and her child. Pre-conception interventions require equipping prospective parents with the necessary knowledge
and skills to make healthy lifestyle choices for themselves and their children. Addressing the promotion of such
health literacy in parents-to-be in low- and middle-income countries requires a wider social perspective. It requires
a range of multisectoral agencies to work together and could be linked to the issues of women’s empowerment, to
reproductive health, to communicable disease prevention and to the Millennium Development Goals 4 and 5.
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Background
The rising incidence of diabetes in both developed and
developing countries [1-3] is generating a large humani-
tarian and financial burden [4]. For example, at least 93
million people are affected by diabetes in China alone
[5]. Especially worrying is the generalized fall in the age
at onset of diabetes [2,6]. With rapidly increasing
globalization, lifestyles in low- and middle-income coun-
tries (LMICs) increasingly include high fat and calorie-
dense diets and inadequate physical exercise and are
resulting in an increased worldwide burden of Non-
Communicable Diseases (NCDs) [7]. LMICs thus now
face a double burden - continued high rates of infectious
diseases and rapidly growing NCD prevalence. Globally,
85% of all people with undiagnosed diabetes are in
LMICs, where resources are often lacking and govern-
ments may not prioritize screening for the condition [3].
In addition, the interaction between diabetes and major
infectious diseases has a large impact on public health
within developing countries (such as in Sub-Saharan
Africa) and adversely affects progress towards the
Millennium Development Goals (MDGs) [8-10]. Poverty,
inequality, lack of education and the nature of the nutri-
tional transition are root causes of the problem [11]
while limited resources mean that NCDs must compete
for political attention and financial investment [10]. Fol-
lowing several recent regional and international meet-
ings and initiatives [12] including the UN high-level
meeting on prevention and treatment of NCDs from
19-20 September 2011 [13], the global threat of diabetes
and other NCDs is beginning to receive greater political
attention. Until recently, there was much publicity for
the view that diabetes and NCDs were largely manifest
in adults as a result of the biblical sins of ‘gluttony and
sloth’, so there was both an urgent need to get indivi-
duals to take more responsibility for their adult lifestyle
and to discourage the food industry from producing the
‘unhealthy’ foods which fuelled this epidemic of disease
[8]. However, a substantial body of evidence makes it
clear that early life influences also play an important part
here, and that maternal (and, to a degree, paternal) life-
style and conditions such as gestational diabetes affect
not only prenatal and infant development but also the
adequacy of responses to later challenges such as an
obesogenic lifestyle. This emphasises the importance of
NCD risk reduction starting in adolescents and young
women before conception and during pregnancy [14].
In this review, we examine the role of early life influ-
ences on diabetes risk, and argue that interventions to
promote diet and lifestyle in prospective parents before
conception have not received sufficient attention, espe-
cially in LMICs undergoing socio-economic transition.
Such interventions will be particularly important in ado-
lescents and young women and seem likely not only to
reduce the prevalence of NCDs in the next generation
but also to reduce that of pregnancy conditions such as
gestational diabetes mellitus (GDM), which predispose
to NCDs in both the mother and her child. We therefore
propose that greater emphasis on promotion of health
literacy, coupled with screening for risk and manage-
ment of chronic health conditions such as obesity and
diabetes, prior to conception will be an important add-
itional approach to tackling the epidemic of NCDs. If ef-
fective, this may be a cost-effective way of addressing the
epidemic of NCDs such as diabetes.
Discussion
Early life influences on diabetes risk
We have argued that diabetes incidence is rising so fast
in young people in LMICs not solely because of the
adoption of attributes of Western lifestyle, but also be-
cause the evolved biology of human early life has not pre-
pared individuals for such a challenge – the mismatch
hypothesis [14]. The operation of maternal constraint
[15,16], by which processes operate to match the growth
of the fetus to maternal body proportions such as pelvic
dimensions, occurs in all pregnancies, and thus makes
each of us potentially mismatched to our postnatal envir-
onment. However, the degree of this mismatch varies.
The processes of maternal constraint, and thus the risk
of later mismatch, appear to operate more powerfully in
teenage pregnancies and in primipara. Thus interven-
tions targeted to this time in the mother’s lifecourse may
be particularly effective in reducing NCD risk in the next
generation.
A body of knowledge is accumulating which suggests
that environmental factors act in early life via epigenetic
factors to set the development of many aspects of the
offspring phenotype, contributing to potential later mis-
match [17]. This model (see Figure 1) posits that critical
components of risk are established early in development,
when information about the current environment affects
the settings of homeostatic control processes influencing
the individual’s responses to their later environment: the
underlying mechanisms involve the evolutionary con-
served processes of developmental plasticity [17,18].
Central to developmental plasticity is the concept that
the mother is able to pass on information about the ex-
ternal environment during pregnancy and nursing of her
infant. The level and fidelity of these processes is influ-
enced by a wide range of factors including mother’s
genetic makeup, her early life, her current nutritional sta-
tus, age, body composition and proportions, lifestyle (es-
pecially level of physical activity, smoking, alcohol
consumption), parity and external stressors such as infec-
tion, pollution etc. [19]. Hence aspects of maternal
phenotype and trans-generational environmental changes
can lead to increased risk of disease in the offspring when
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what has been promised about the environment, ‘inferred’
from intrauterine or neonatal cues, turns out not to be
accurate. Such a mismatch between the biology induced
during prenatal life and later environment has been sug-
gested to increase the risk of NCDs being passed from
one generation to the next; it is supported by extensive
experimental and clinical data [17,20].
The risk of NCD such as diabetes is present in
everyone and increases throughout the lifecourse. In
women the insulin resistance of pregnancy increases
such risk (upward excursions shown here for two
pregnancies), particularly of GDM but also of type 2
diabetes and cardiovascular disease. This contributes
to transmission of NCD risk to the next generation.
Early development affects the trajectory of this risk,
thus a focus on health before conception reduces
NCD risk in both the mother and her children
(based on Godfrey et al., 2010 [19] and Sattar and
Greer, 2002 [43].
Diabetes begetting diabetes and the role of gestational
diabetes and maternal obesity
The processes noted above do not constitute the only
developmental pathway leading to intergenerational pas-
sage of risk of NCDs. It is alarming that an increasing
number of women develop type 2 diabetes during their
reproductive years [21,22]. Epidemiological studies show
that children born to type 1 or 2 diabetic mothers also
have a greater susceptibility to diabetes and obesity in
later life [23,24]. That this risk is related to intra-uterine
exposure to hyperglycaemia is shown by the observation
that, among siblings, the risk of diabetes is higher in
those born after the mother was diagnosed with diabetes
[25]. These observations have been extended recently, as
offspring exposed even to mild hyperglycaemia during
pregnancy have increased adiposity and are at increased
risk of later diabetes and cardiometabolic disease
[26,27]. Through perpetuation of the cycle of ‘diabetes
begetting diabetes’, these factors are driving further es-
calation of the epidemic of NCDs [28,29]. Recent animal
data now also raise the possibility of paternal transmission
of diabetes risk between generations [30] so the focus of
potential interventions should not only be on women.
The rising prevalence of maternal obesity is of particu-
lar concern in populations undergoing rapid socio-
economic transitions [1,2,21]. Obesity is associated with
an increased risk of many pregnancy complications such
as hypertension, preeclampsia, and GDM. Evidence
shows that a child of an obese mother may suffer from
exposure to a suboptimal environment in utero and is
also more likely to become obese [31,32]. Experimentally
feeding pregnant animals a high fat diet gives rise to off-
spring who become overweight and who demonstrate a
range of metabolic and functional disorders similar to
the human metabolic syndrome and which have now
been shown to be associated with epigenetic changes
such as DNA methylation at components of genes
involved in hepatocyte production and metabolism, [33].
Low risk trajectory
In life with normal pregnancies
High risk trajectory
In life with normal pregnancies
High risk trajectory
exacerbated by GDM pregnancies
NCD
Risk 
In Mother
1st GDM
Pregnancy
2nd GDM
Pregnancy
Corresponding
NCD Risk
In First Offspring
Low risk trajectory
High risk trajectory
Pregnancy
Lifecourse
Pregnancy
plasticity Inadequate response
to new challenges
Healthy diet,  
lifestyle and body 
composition pre- 
conception  reduce 
later risk
High risk trajectory with 
transgenerational effect
Figure 1 The risk of NCD in mother and offspring increases with each pregnancy.
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Pregnancy represents a state of relative maternal insulin
resistance, which helps promote the transfer of nutrients
such as glucose, fatty acids and amino acids to the fetus
[34]. Placental nutrient transfer is determined by the
concentration gradient, blood flow and the operation of
active and facilitated transporters [35]. However, in con-
trast to amino acids, there is no upper limit to placental
transfer of glucose as maternal blood levels rise, suggest-
ing that the rates of glucose exposure of the fetus that
are often now experienced are novel in evolutionary
terms. As a result, moderately increased fetal glucose
supply will lead to fetal hyperinsulinaemia and a small
increase in lean body as well as fat mass [36-39]. This
may be viewed as adaptive as in the neonatal period
relative adiposity provides metabolic reserves for
thermogenesis and critical organ function in the event of
inadequate maternal care [18]. GDM can be envisaged
as the more extreme outcome of physiological processes,
when maternal insulin resistance is accentuated by the
woman’s own developmental, genetic and environmental
circumstances: for example, women of lower birth
weight have a greater risk of developing GDM [37],
whilst genetic variants associated with type 2 diabetes
are also associated with increased risk of GDM [40,41].
In the evolutionary mismatched situation of over-
nutrition and low levels of physical activity, now increas-
ingly common for women in their reproductive years,
such mechanisms contribute not only to the rise in
GDM but to that in obesity and diabetes in their chil-
dren, and play an important role in perpetuating a vi-
cious cycle of disease. For example, a recent paper
shows that in Canadian first nation peoples up to 30% of
the incidence of type 2 diabetes has its origin in GDM in
the previous generation [42]. Conditions such as GDM
carry risk of cardiovascular disease for both the mother
as well as the child, a risk which increases with each
pregnancy (Figure 1) [43]. These findings have signifi-
cant long-term implications for global public health.
Now more than ever, effective strategies for preventing
GDM are needed.
Current public health strategies in adults have limited
success
Most interventions to promote diet and lifestyle aimed at
reducing overweight/ obesity, and thus the risk of NCDs
such as diabetes later in life, have focused on adults. How-
ever, evidence suggests that interventions aimed at weight
loss in adults or to prevent excessive weight gain during
pregnancy and subsequent weight retention have had lim-
ited success. First, weight loss and persistent changes in
lifestyle are difficult to sustain in adults because the neuro-
endocrine changes that drive appetite remain unaltered
[44]. There is growing evidence of antenatal and infant
determinants of appetite and food preference that persist
through adult life [45-47]. Therefore relying on adult re-
versal of weight gain as a preventative approach is a flawed
strategy in developed countries and is even more likely to
be flawed in less developed societies. In addition, greater
maternal pre-pregnancy weight and gestational weight
gain up to 36 weeks of gestation are associated with
greater offspring adiposity and adverse cardiovascular risk
factors [48]. Finally, recent evidence shows that risk fac-
tors for diabetes and cardiovascular disease are no greater
in non-obese adults who had been obese children than
they are in individuals who had never been obese, but are
clearly less than those in people who became obese as
adults or who were obese both as children and adults [49].
This makes a strong case for focusing earlier in life before
appetite control, food preference and fat cell number are
established, and before obese children reach adulthood.
Intervening from conception – the 1000 days
There has been much publicity on the 1000 days cam-
paign to improve nutrition of mothers and children in
developing countries launched by the 1st Lady of the
USA (http://www.thousanddays.org/). This period of life
covers a woman’s pregnancy and the first 2 years of her
child’s postnatal life, a time when the processes of devel-
opmental plasticity operate powerfully to influence off-
spring phenotype and when excessive growth, as
determined by crossing of more than 2 centiles is asso-
ciated with later adiposity in childhood [50]. Despite a
unique window of opportunity to shape the healthy fu-
ture of mothers and children during this period, findings
are inconsistent in relation to which factors need to be
targeted in interventions to reduce the risk of later
NCDs such as diabetes. First, even though evidence
shows that preventing excessive gestational weight gain
improves maternal, neonatal and pregnancy outcomes
such as the risk of preeclampsia, preterm delivery and
gestational diabetes [51-54], there is limited evidence of
interventions to manage weight during this period being
effective [55,56]. Poor intervention effectiveness seems
to be related to inadequately addressing (social) barriers
that women experience in achieving a healthy weight
gain in pregnancy, such as a perceived lack of control
and contradictory and conflicting messages about nurt-
uring behaviours during pregnancy [56]. Pregnancy is a
time of when many influences operate on parents and it
may not be the best time for messages to be delivered
about preventing excessive weight gain in women. Sec-
ondly, there is a growing body of evidence that breast
feeding for at least 4 months leads to a reduction in
long-term obesity in the child [57,58] and that the intro-
duction of solids before the age of 4 months both in
formula- or breast-fed infants is associated with later
obesity [59]. A recent study [60] suggests that self-
weaned children are less likely to become obese,
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showing that relatively subtle changes in infant care may
have long-term effects. Despite the overwhelming evi-
dence that breastfeeding benefits mother and child,
current breastfeeding rates worldwide are far from opti-
mal, particularly among low-income, overweight and
obese women [61,62]. Breastfeeding initiation and dur-
ation, and its exclusivity, are positively associated with
the age, educational level and SES of the mother, while
there is an inverse pattern for early formula and cow’s
milk consumption [62]. Again, a woman's ability to ad-
here to health recommendations (in this case to infant
feeding practices) seems to be influenced by a wide
range of socio-economic and cultural variables. In con-
trast to intervention to reduce excessive weight gain dur-
ing pregnancy, treatment of mild gestational diabetes
was associated with reduced risk of fetal overgrowth or
adiposity at birth [63,64].
There is some evidence that home-based early mentor-
ing interventions, focusing on interpreting infants' cues,
non-food methods of managing infant behavior, and
mother-grandmother interactions are effective in improv-
ing infant feeding practices and delaying early comple-
mentary infant feeding among adolescent and low-income
mothers [65,66]. This indicates that multiple types of
interventions, including community based strategies such
as educating young girls, the wider family and the social
network, are needed to address this complex health prob-
lem, especially in disadvantaged groups.
Potential early life interventions- intervening before
conception is critical
A very important factor in the prevention of the devel-
opmental component of diabetes risk is the physiological
state in which the parents enter pregnancy – i.e. the diet,
body composition and lifestyle of the mother and to a
lesser extent the father. There is considerable data from
experimental studies in a range of animal species and
prospective studies in humans that the mother’s diet and
body composition before and in early pregnancy are
related to phenotypic characteristics of the child, such as
adiposity at birth and in childhood, and markers of car-
diovascular risk such as carotid artery intima-media
thickness [67-69]. The processes involved in influencing
embryonic and fetal development are gradually being
unravelled. Both animal and human studies reveal effects
on placental function [70], the development of fetal
organ function and on epigenetic processes in the off-
spring early in development [71]. Most couples will
not be aware that they have conceived until after about
6-8 weeks of pregnancy, especially in societies where a
high proportion of pregnancies are unplanned. Lower
SES women tend to link with health care professionals
later in pregnancy. Thus interventions in mid-late preg-
nancy will be too late to produce the largest effects on
the health of the child and his/her later risk of NCDs.
Moreover teenage pregnancy occurs at a time when the
girl is still growing: resources are allocated to this
growth rather than to her fetus, further compromising
its development. In recently conducted research in the
UK, it is clear that maternal diabetes during pregnancy
is accompanied by a greater risk of birth defects and
complicated pregnancy outcomes [41]. Therefore it is
important that women and their partners are screened
for risk factors before they plan pregnancy to improve
health outcomes for both the mother and offspring.
The relation between overweight/ obesity and NCD
such as diabetes, is clearly not simple [72] and interven-
tions need to be multifaceted and incorporated into social
context. So far, very few interventions to reduce childhood
obesity have been set up at the community level [73] and
outside the school environment [74]. Community-based
interventions are particularly important in societies where
teenage girls who may be married at a very young age and
become pregnant soon after, or who may have an un-
planned pregnancy, and are more likely to cease attending
school. We argue that focussing interventions on the ado-
lescent girl, and her partner, necessitates promotion of
health literacy, such as lifestyle, family planning and the
importance of breastfeeding. Health literacy means more
than being able to read pamphlets and successfully make
appointments. By improving people’s access to health in-
formation and their capacity to use it effectively, health lit-
eracy is critical to empowerment [75]. Health literacy in
adolescents is more likely to be taken to the highest level
of critical thinking about health and lifestyle if it is made
context-specific and conducted outside the school envir-
onment, which is associated with authority and which
may not be available to many girls in particular. Low
health literacy affects the cognitive and social skills that
determine the motivation and ability of women to gain ac-
cess to, understand, and use information to engage in
health promotion and prevention activities both for her
and her (future) children [76-78]. Children of parents with
higher literacy skills are more likely to have better out-
comes in child health promotion and disease prevention
[79]. It has been suggested that health education interven-
tions that include clearly written education material that
are appropriate for (future) parents’ health knowledge with
brief counselling would be an effective strategy to reduce
health literacy-related disparities [76,77].
Delivering pre-conception interventions in LMICS
Delivering these interventions should be done carefully
and after identifying the right channels. In many coun-
tries the existing public health programmes which focus
on sexual and reproductive health may offer opportun-
ities to deliver such interventions in a cost effective
manner to adolescents and women of reproductive age.
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However, our experience [80] is that effective pro-
grammes may need to pay close attention to the peda-
gogical approach used which will have to be tailored to
the community. It is important that measures of harm
or unintended consequences are included in evaluations
targeting eating and activity related behaviours in ado-
lescents, where body image sensitivities are common
and could possibly result in causing unintended conse-
quences such as stigmatisation, low self-esteem or un-
healthy dieting practices [81]. An additional challenge in
trying to improve adolescents’ nutrition or physical ac-
tivity is that some cultures have less negative views on
overweight individuals and a larger body type is accepted
socio-culturally, or even found desirable as a sign of
prosperity or being HIV negative. It will be critical to
incorporate the positive elements of such culture
regarding body image and food rather than attempting
to shift values toward those of Western culture [82].
Four million neonatal deaths occur every year [83],
many in LMICs, and there is universal concern that the
goal of MDG-4 to promote child survival will not be
met in most settings. Considerable reductions in this
mortality, in a cost-effective manner, can be achieved by
implementing an integrated programme combining out-
reach and family-community care with facility-based
clinical services [84]. In our view it is important that
emphasis on preventing maternal and neonatal mortality
does not occur at the expense of adopting a longer-term
lifecourse strategy, starting pre-conception [85], needed
for NCD prevention. However it is pleasing to note that
the Political Declaration at the High Level meeting on
NCDs at the UN in Sept 2011 specifically recognised the
important role of maternal and child health in NCD
prevention (clause 26)[13].
Based on the evidence presented in this review, we be-
lieve that real opportunities exist for developing
community-based family-lifestyle change interventions
to improve access to and use of reliable information on
NCDs and to promote a healthy lifestyle among adoles-
cents and young women in LMICs. There is an urgent
need to conduct research on pilot schemes tailored to
this subgroup. These will need to be based in the com-
munity and relate to socio-economic factors [84,85], be
culturally appropriate and context specific and involve
primary health care workers, schools, parents and care-
givers and other social organisations. They may need to
include simple health-monitoring or exercise tests and
screening for blood glucose, for which the results can be
used to monitor effectiveness and also fed back to parti-
cipants to maintain motivation and self-efficacy [81].
Such programmes are perhaps best piloted in societies
where there is a proven track-record in health promo-
tion, e.g. through HIV-AIDS programmes, and where
there is existing infrastructure to accelerate results.
Indeed, it will be important that such pilot schemes are
integrated into, rather than compete with, other pro-
grammes in sexual health, drug, smoking and alcohol
consumption reduction etc. Such a programme would
then dovetail with antenatal health monitoring pro-
grammes, and with the early diagnosis and prevention of
conditions such as GDM. For the latter, many of the first
line intervention options such as diet, physical exercise
and weight control are similar to the behaviours to be
promoted in adolescents before conception. The
programme would similarly link effectively with MCH
initiatives aimed at reducing preterm- and stillbirth and
maternal mortality and with postnatal healthcare pro-
grammes, aimed at promoting breast feeding, healthy
supplementary and weaning foods, vaccination etc. The
burden of NCDs impacts heavily on women’s health and
integrating NCD prevention and control into maternal
and child health programmes will improve access to
NCD services [86]. This approach requires an agenda
broader than health agencies alone and it would be de-
sirable that a broader range of global agencies such as
UNDP, UNESCO, UNICEF, and UN Women became
active alongside WHO [87].
Discussion: seeing the bigger picture
The long-term consequences of a poor start to life include
greater risk of NCDs such as diabetes and cardiovascular
disease as well as greater risks of childhood morbidity and
mortality and impaired cognitive and emotional develop-
ment. Just as cycles of disadvantage in one generation lead
to disadvantage in the next, obesity, gestational diabetes,
maternal ill health and under-nutrition can lead to health
disparities and disease in the next generation. The per-
ceived long time lag between instituting an intervention in
early life and detecting a beneficial effect on NCD inci-
dence in adults has inevitably reduced the sense of ur-
gency in implementing such interventions, particularly in
the context of short-term outcomes such as maternal or
child mortality and communicable disease. However we
are now in a position to use shorter-term intermediate
outcome markers of later disease risk to monitor and pro-
mote a healthy start to life programmes such as those in
pre-conception care. Such programmes might demon-
strate: a reduction in cardio-metabolic risk factors in ado-
lescents; reduced occurrence or severity of GDM;
improvement in pregnancy outcomes such as macroso-
mia, dystocia and hypoglycaemia of the neonate. For such
interventions the evidence base is strong. For other inter-
mediate outcome markers, such as a healthier profile of
epigenetic markers at birth in umbilical cord, placenta or
cord blood, the evidence base is rapidly accumulating.
Postnatally there are also opportunities to use outcome
markers, for example trajectories of growth in the first
two years [50], profiles of inflammatory and other
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biomarkers in children [88]; and incidence of some infant
and early childhood disorders such as wheeze and asthma
[89]. Clearly, the earlier and intervention is instituted, the
more likely it is to be effective. There is thus an urgent
need to conduct pre-conception interventions, to measure
their efficacy and conduct cost-benefit analysis of this
approach to NCD risk reduction.
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